Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Jun-24 9:00 PM View:  | Y-Mabs Therapeutics, Inc. (YMAB) | 11-Jun-24 | Grant | 3,495 | -- | -- | 150% 2.33K to 5.83K | |
| 15-May-24 5:20 PM View: | Evolus, Inc. (EOLS) | 14-May-24 | Sale | 6,718 | $12.60 | $84,653.50 | (17%) 40.68K to 33.96K | |
| 15-May-24 5:20 PM View: | Evolus, Inc. (EOLS) | 13-May-24 | Private Sale | 3,643 | $12.72 | $46,356.10 | (8%) 44.33K to 40.68K | |
| 09-Feb-24 6:37 PM View: | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 6,464 | -- | -- | 17% 37.86K to 44.33K | |
| 09-Jun-23 6:01 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 08-Jun-23 | Grant | 2,330 | -- | -- | 100% 0 to 2.33K | |
| 31-Jan-23 8:41 PM View: | Evolus, Inc. (EOLS) | 27-Jan-23 | Grant | 8,293 | -- | -- | 28% 29.57K to 37.86K | |
| 17-May-22 6:49 PM View: | Evolus, Inc. (EOLS) | 16-May-22 | Sale | 5,000 | $13.62 | $68,080.00 | (14%) 34.57K to 29.57K | |
| 17-May-22 6:49 PM View: | Evolus, Inc. (EOLS) | 13-May-22 | Private Sale | 5,313 | $13.10 | $69,584.40 | (13%) 39.88K to 34.57K | |
| 26-Jan-22 9:01 PM View: | Evolus, Inc. (EOLS) | 24-Jan-22 | Grant | 15,568 | -- | -- | 64% 24.31K to 39.88K | |
| 06-Oct-21 7:41 PM View: | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 78,058 | -- | -- | (100%) 78.06K to 0 | |
| 05-Oct-21 7:21 PM View: | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise | 17,763 | $2.06 | $36,591.80 | (19%) 95.82K to 78.06K | 4% |
| 18-May-21 7:10 PM View: | Strongbridge Biopharma Plc (SBBP) | 18-May-21 | Grant | 40,000 | -- | -- | 72% 55.82K to 95.82K | |
| 17-May-21 6:29 PM View: | Strongbridge Biopharma Plc (SBBP) | 14-May-21 | Payment of Exercise | 19,075 | $2.35 | $44,826.20 | (25%) 74.9K to 55.82K | 16% |
| 09-Feb-21 5:13 PM View: | Evolus, Inc. (EOLS) | 05-Feb-21 | Grant | 19,313 | -- | -- | 386% 5.0K to 24.31K | |
| 20-Jan-21 4:16 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 19-Jan-21 | Option Exercise | 2,000 | $11.16 | $22,320.00 | 100% 0 to 2.0K | |
| 20-Jan-21 4:16 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 19-Jan-21 | Market Option Sale (Planned) | 2,000 | $46.52 | $93,045.20 | (100%) 2.0K to 0 | |
| 20-Nov-20 4:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 18-Nov-20 | Option Exercise | 2,000 | $11.16 | $22,320.00 | 100% 0 to 2.0K | |
| 20-Nov-20 4:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 18-Nov-20 | Market Option Sale | 2,000 | $45.76 | $91,530.00 | (100%) 2.0K to 0 | (17%) |
| 05-Nov-20 5:51 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 03-Nov-20 | Option Exercise | 4,000 | $11.16 | $44,640.00 | 100% 0 to 4.0K | |
| 05-Nov-20 5:51 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 03-Nov-20 | Market Option Sale | 4,000 | $45.00 | $180,000.00 | (100%) 4.0K to 0 | (19%) |
| 28-Sep-20 7:48 AM View: | Strongbridge Biopharma Plc (SBBP) | 24-Sep-20 | Market Purchase | 8,000 | $2.13 | $17,040.00 | 12% 66.9K to 74.9K | (8%) |
| 04-Sep-20 4:28 PM View: | Strongbridge Biopharma Plc (SBBP) | 03-Sep-20 | Payment of Exercise | 23,104 | $3.61 | $83,405.40 | (26%) 90.0K to 66.9K | 45% |
| 15-May-20 4:47 PM View: | Strongbridge Biopharma Plc (SBBP) | 14-May-20 | Grant | 40,000 | -- | -- | 80% 50.0K to 90.0K | |
| 26-Nov-19 4:33 PM View: | Electro-Optical Sciences, I... (SSKN) | 22-Nov-19 | Grant | 18,293 | -- | -- | 39% 46.4K to 64.69K | |
| 04-Sep-19 4:19 PM View: | Strongbridge Biopharma Plc (SBBP) | 03-Sep-19 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 14-Jun-19 9:59 PM View: | Evolus, Inc. (EOLS) | 13-Jun-19 | Market Purchase | 2,000 | $13.65 | $27,300.00 | 67% 3.0K to 5.0K | (72%) |
| 17-Dec-18 9:51 PM View: | Evolus, Inc. (EOLS) | 14-Dec-18 | Purchase | 3,000 | $12.77 | $38,300.10 | 100% 0 to 3.0K | |
| 30-May-18 10:00 PM View: | Cempra, Inc. (MLNT) | 25-May-18 | Market Purchase | 5,000 | $6.09 | $30,450.00 | 500% 1.0K to 6.0K | (78%) |
| 17-Aug-17 5:00 PM View: | Ocugen, Inc. (OCGN) | 16-Aug-17 | Market Purchase | 3,000 | $1.81 | $5,439.00 | 27% 11.0K to 14.0K | (99%) |
| 17-May-17 5:00 PM View: | Ocugen, Inc. (OCGN) | 16-May-17 | Market Purchase | 3,000 | $1.68 | $5,040.00 | 38% 8.0K to 11.0K | (98%) |
| 04-Jan-17 7:46 AM View: | Cempra, Inc. (MLNT) | 03-Jan-17 | Market Purchase | 5,000 | $2.94 | $14,720.00 | 100% 0 to 5.0K | (91%) |
| 15-Dec-16 5:15 PM View: | Ocugen, Inc. (OCGN) | 15-Dec-16 | Market Purchase | 3,000 | $1.65 | $4,950.00 | 60% 5.0K to 8.0K | (98%) |
| 15-Dec-16 5:00 PM View: | Ocugen, Inc. (OCGN) | 09-Dec-16 | Market Purchase | 5,000 | $1.92 | $9,600.00 | 100% 0 to 5.0K | (99%) |
| 23-Nov-16 10:21 AM View: | EndoChoice Holdings, Inc. (GI) | 22-Nov-16 | Disposition | 125,445 | $8.00 | $1,003,560.00 | (76%) 164.03K to 38.59K | |
| 23-Nov-16 10:21 AM View: | EndoChoice Holdings, Inc. (GI) | 22-Nov-16 | Disposition | 38,585 | $8.00 | $308,680.00 | (100%) 38.59K to 0 | |
| 31-Mar-16 4:18 PM View: | EndoChoice Holdings, Inc. (GI) | 29-Mar-16 | Grant | 14,826 | -- | -- | 10% 149.2K to 164.03K | |
| 10-Mar-16 4:30 PM View: | EndoChoice Holdings, Inc. (GI) | 10-Mar-16 | Market Purchase | 2,000 | $4.70 | $9,400.00 | 1% 147.2K to 149.2K | (< 1%) |
| 07-Mar-16 4:45 PM View: | EndoChoice Holdings, Inc. (GI) | 07-Mar-16 | Market Purchase | 5,000 | $4.77 | $23,850.00 | 4% 142.2K to 147.2K | (7%) |
| 17-Aug-15 7:05 PM View: | EndoChoice Holdings, Inc. (GI) | 14-Aug-15 | Grant | 53,825 | -- | -- | 61% 88.38K to 142.2K | |
| 16-May-07 3:20 PM View: | LeMaitre Vascular, Inc. (LMAT) | 16-May-07 | Market Purchase | 800 | $6.05 | $4,840.00 | 13% 6.0K to 6.8K | 669% |
| 16-May-07 3:20 PM View: | LeMaitre Vascular, Inc. (LMAT) | 15-May-07 | Market Purchase | 200 | $6.03 | $1,206.00 | 3% 5.8K to 6.0K | 671% |
| 10-May-07 2:00 PM View: | LeMaitre Vascular, Inc. (LMAT) | 09-May-07 | Market Purchase | 1,000 | $6.25 | $6,250.00 | 21% 4.8K to 5.8K | 644% |
| 22-Dec-06 7:22 PM View: | LeMaitre Vascular, Inc. (LMAT) | 22-Dec-06 | Grant | 2,805 | -- | -- | 140% 2.0K to 4.8K | |
| 01-Nov-06 4:11 PM View: | LeMaitre Vascular, Inc. (LMAT) | 31-Oct-06 | Market Purchase | 2,000 | $6.05 | $12,100.00 | 100% 0 to 2.0K | 669% |
| 15-May-06 9:22 PM View: | Nxstage Medical, Inc. (NXTM) | 10-May-06 | Grant | 7,422 | -- | -- | 37110% 20 to 7.44K | |
| 06-May-05 6:11 PM View: | Cti Molecular Imaging Inc (CTMI) | 29-Apr-05 | Disposition (change in control) | 93,000 | $20.50 | $1,906,500.00 | (94%) 99.4K to 6.4K | |
| 06-May-05 6:11 PM View: | Cti Molecular Imaging Inc (CTMI) | 29-Apr-05 | Disposition (change in control) | 6,400 | $20.50 | $131,200.00 | (100%) 6.4K to 0 | |
| 19-Jan-05 3:15 PM View: | Cti Molecular Imaging Inc (CTMI) | 18-Jan-05 | Option Exercise | 9,700 | $4.69 | $45,468.80 | 11% 89.7K to 99.4K | |
| 19-Oct-04 10:00 PM View: | Cti Molecular Imaging Inc (CTMI) | 18-Oct-04 | Option Exercise | 10,501 | $4.69 | $49,223.40 | 13% 79.2K to 89.7K | |
| 18-Oct-04 10:00 PM View: | Cti Molecular Imaging Inc (CTMI) | 14-Oct-04 | Option Exercise | 12,799 | $4.69 | $59,995.30 | 19% 66.4K to 79.2K |